About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Vinorelbine
- Procedure number
- PSUSA/00003124/202204
- Regulatory outcome
- Variation
Documents
Vinorelbine : List of nationally authorised medicinal products - PSUSA/00003124/202204
English (EN) (226.24 KB - PDF)
Vinorelbine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00003124/202204
English (EN) (92.05 KB - PDF)
български (BG) (163.03 KB - PDF)
español (ES) (67.48 KB - PDF)
čeština (CS) (135.06 KB - PDF)
dansk (DA) (65.81 KB - PDF)
Deutsch (DE) (80.36 KB - PDF)
eesti keel (ET) (78.04 KB - PDF)
ελληνικά (EL) (153 KB - PDF)
français (FR) (67.7 KB - PDF)
hrvatski (HR) (138.53 KB - PDF)
íslenska (IS) (66.15 KB - PDF)
Gaeilge (GA) (67.33 KB - PDF)
italiano (IT) (85.29 KB - PDF)
latviešu valoda (LV) (136.3 KB - PDF)
lietuvių kalba (LT) (140.26 KB - PDF)
magyar (HU) (135.12 KB - PDF)
Malti (MT) (139.93 KB - PDF)
Nederlands (NL) (67.77 KB - PDF)
norsk (NO) (74.73 KB - PDF)
polski (PL) (140.22 KB - PDF)
português (PT) (75.32 KB - PDF)
română (RO) (133.73 KB - PDF)
slovenčina (SK) (151.98 KB - PDF)
slovenščina (SL) (132.06 KB - PDF)
Suomi (FI) (71.61 KB - PDF)
svenska (SV) (66.96 KB - PDF)